The folate receptor (FR) has been identified as a new molecularly targeted entity, which is highly overexpressed on the surface of a spectrum of solid tumor cells, including ovarian, kidney, lung, brain, endometrial, colorectal, pancreatic, gastric, prostate, testicular, bladder, head and neck, breast, and non-small cell lung cancer.
Targeted therapies that increase cancer cell sensitivity to chemotherapies offer the benefits of lowering unwanted side effects and increasing the likelihood of destroying resistant cells while avoiding healthy cells where there is little or no expression of the targeted entity.
"We are the central data and targeting entity," said Greg Speed, executive director at America Votes.
A single-chain Fragment variable (scFv) of the murine monoclonal antibody MAb-B43.13 MAb-B43.13CA125 in epitargetingvarian CA125r was previnusly depithelialexpressed, purified and provarianas a funcancerl targeting entity for biomedical applications.
The MTS peptide, MLRAALSTARRGPRLSRLL, a well-studied natural presequence from the mitochondrial-oriented protein aldehyde dehydrogenase (ALDH), was selected as the mitochondrial targeting entity.
Direct chemical conjugation to cells of a targeting entity, such as an antibody or a fragment derived from it is not straightforward and requires reaction conditions that may be toxic to cells and that could affect the properties of the entity attached.
Due to the missing tumor targeting entity, the observed tumor accumulations were faint and also a high unspecific accumulation of the compounds in nontarget organs such as liver, spleen, gut, lung, and blood was observed [ 41, 42, 44], limiting the usefulness of these compounds for in vivo tumor imaging.
Spectators are prone to applauding pranks that target entities they deem worthy of targeting.
He introduced vehicles that allowed Fed lending to target entities whose insolvency would pose severe risks to the system.
Activists could also target entities that take advantage of the commons energy companies, internet giants, pharmaceutical firms profiting from publicly funded research and hold sit-ins outside their doors until they pay into the fund.
In general drug immunoconjugates are composed of targeting entities (mainly mAbs) chemically conjugated to a cytotoxic drug.
